We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial

    Aims/hypothesis

    In the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) trial, dapagliflozin reduced the risks of...

    Simke W. Waijer, Priya Vart, ... Hiddo J. L. Heerspink in Diabetologia
    Article Open access 21 April 2022
  2. Polygenic Risk Scores for Breast Cancer

    Purpose of Review

    Polygenic risk scores (PRS) for breast cancer (BC) estimate risk based on the cumulative impact of single-nucleotide polymorphisms....

    Kaitlin Demarest, Payal D. Shah in Current Breast Cancer Reports
    Article 08 February 2024
  3. Establishment and Validation of a Risk Prediction Model for Non-Invasive Ventilation Failure After Birth in Premature Infants with Gestational Age < 32 Weeks

    Objectives

    This study was performed to construct and validate a risk prediction model for non-invasive ventilation (NIV) failure after birth in...

    Fei Shen, Meng-ya Yu, ... Yang Yang in Lung
    Article 03 July 2024
  4. Comparison of diagnosis-based risk adjustment methods for episode-based costs to apply in efficiency measurement

    Background

    The recent rising health spending intrigued efficiency and cost-based performance measures. However, mortality risk adjustment methods are...

    Juyoung Kim, Minsu Ock, ... Sang-il Lee in BMC Health Services Research
    Article Open access 01 December 2023
  5. Development of a novel dynamic nosocomial infection risk management method for COVID-19 in outpatient settings

    Background

    Application of accumulated experience and management measures in the prevention and control of coronavirus disease 2019 (COVID-19) has...

    Yuncong Wang, Lihong Wang, ... **a Zhao in BMC Infectious Diseases
    Article Open access 19 February 2024
  6. Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials

    Purpose

    Reduction of major atherosclerotic cardiovascular events (MACE) has not been consistent among different glucagon-like peptide-1 receptor...

    Daniel A. Gomes, João Presume, ... Jorge Ferreira in Cardiovascular Drugs and Therapy
    Article 12 January 2024
  7. Reduction of sugar, salt and fat content in foods over the period 2016–2021 in Spain: the National Food Reformulation Plan

    Background/objectives

    Population´s dietary intake of saturated fat, sodium, and sugars is higher than the current recommendations in Spain and most...

    María José Yusta-Boyo, Enrique Gutiérrez González, ... Fernando Rodríguez-Artalejo in European Journal of Clinical Nutrition
    Article 24 October 2023
  8. Blood volume reduction due to rapid plasma loss after birth in preterm piglets

    Background

    Understanding changes in blood volume after preterm birth is critical to preventing cardiovascular deterioration in preterm infants. The...

    Tam M. T. Nguyen, Holly Morwood, ... Yvonne A. Eiby in Pediatric Research
    Article Open access 21 May 2024
  9. Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020–2022

    COVID-19 is associated with increased risks for mood or anxiety disorders, but it remains uncertain how the association evolves over time or which...

    Christina X. Wang, Rhea Kohli, ... Pamela B. Davis in Molecular Psychiatry
    Article Open access 18 January 2024
  10. Predicting cognitive function and dementia risk in patients with hypertension

    In spite of the fact that hypertension stand out as the main vascular risk factor for develo** dementia, it is essential to acknowledge the...

    Gustavo H. Cerezo, Ruth A. Fernández, ... Facundo Risso Patrón in Hypertension Research
    Article 02 April 2024
  11. Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus

    Aims/hypothesis

    People with diabetes have an increased cardiovascular risk with an accelerated development of atherosclerosis and an elevated...

    Christina Kohlmorgen, Stephen Gerfer, ... Maria Grandoch in Diabetologia
    Article Open access 16 June 2021
  12. Larysuicide: an online risk stratification system to identify patients at high risk of suicide after the laryngeal cancer diagnosis

    Background

    Patients with laryngeal cancer have more than five times the incidence of suicide compared with the general population. In this study, we...

    Zegui Tu, Caili Li, ... Jieyan Luo in Journal of Cancer Research and Clinical Oncology
    Article 10 February 2023
  13. The Clinical Efficacy and Safety of Bempedoic Acid in Patients at Elevated Risk of Cardiovascular Disease: A Meta-Analysis of Randomized Clinical Trials

    Purpose

    Statins are first-line agents to reduce low-density lipoprotein cholesterol (LDL-C) and cardiovascular risk, however, they are insufficient...

    Ahmed Sayed, Omar Shazly, ... Salim S. Virani in Cardiovascular Drugs and Therapy
    Article Open access 01 June 2023
  14. Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention

    Background

    Current guidelines recommend a stepwise initiation of lipid-lowering therapy after percutaneous coronary interventions (PCI) in...

    Achim Leo Burger, Nora Beran, ... Kurt Huber in Wiener klinische Wochenschrift
    Article 24 October 2023
  15. Iron deficiency at birth and risk of hidden hearing loss in infants modification by socioeconomic status: mother-newborn cohort in Shenyang, China

    Objective

    The diagnosis of hidden hearing loss (HHL) in calm state has not yet been determined, while the nutritional status is not involved in its...

    Shuai Hao, Wei Song, ... Fei Yu in BMC Public Health
    Article Open access 03 April 2024
  16. Effectiveness of prophylactic pharmacological hemostatic agents for reduction of blood loss at vaginal surgery: a systematic review and meta-analysis

    Introduction and hypothesis

    The objective was to evaluate the effectiveness of pharmacological hemostatic agents in the reduction of blood loss at...

    Yiming Cui, Innie Chen, ... Aisling Clancy in International Urogynecology Journal
    Article 16 August 2023
  17. Risk factor contributions to socioeconomic inequality in cardiovascular risk in the Philippines: a cross-sectional study of nationally representative survey data

    Background

    Primary prevention of cardiovascular diseases (CVD) increasingly relies on monitoring global CVD risk scores. Lack of evidence on...

    Callum Brindley, Tom Van Ourti, ... Owen O’Donnell in BMC Public Health
    Article Open access 12 April 2023
  18. Absolute treatment effects for the primary outcome and all-cause mortality in the cardiovascular outcome trials of new antidiabetic drugs: a meta-analysis of digitalized individual patient data

    Aims

    Treatment effects from the large cardiovascular outcome trials (CVOTs) of new antidiabetic drugs are almost exclusively communicated as hazard...

    Oliver Kuss, Cihan Akbulut, ... Georg Wolff in Acta Diabetologica
    Article Open access 25 July 2022
  19. The Burden of Cardio-Cerebrovascular Risk Factors: Differences Between Individual Risk and Population Risk

    Introduction

    Cardio-cerebrovascular (CCV) disease contributes significantly to the global burden of disease, with dramatic consequences in terms of...

    Eduardo Capuano, Federica Marchese, ... Vincenzo Capuano in High Blood Pressure & Cardiovascular Prevention
    Article 15 October 2021
Did you find what you were looking for? Share feedback.